GLP-1 weight loss drugs like Ozempic and Wegovy are being promoted as quick solutions for weight loss, but growing concerns remain about serious side effects and long-term health risks. These drugs alter digestion, suppress appetite, and impact multiple metabolic systems. Reports of digestive complications, muscle loss, nutritional deficiencies, and thousands of lawsuits raise important questions about the safety of using powerful medications for cosmetic weight loss.

Ozempic “mouth” refers to reported oral and facial changes seen in increasing number of users of the drug, including dryness, taste alterations, gum issues, and visible volume loss around the mouth. The exact cause remains unknown and may involve direct drug effects, metabolic changes, or rapid weight loss. These reports highlight the need for greater scrutiny, informed consent, and careful evaluation of emerging side effects.

This is a "YouTube PREVIEW" of Russel Brand's daily one-hour RUMBLE show with guest Calley Means (@calleymeans). Calley is an ex-BIG Food...